Linking of N-Myc to death receptor machinery in neuroblastoma cells

被引:35
作者
Cui, HJ [1 ]
Li, T [1 ]
Ding, HF [1 ]
机构
[1] Med Coll Ohio, Dept Biochem & Canc Biol, Toledo, OH 43614 USA
关键词
D O I
10.1074/jbc.M410450200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The oncogene MYCN is amplified in aggressive neuroblastomas in which caspase-8, an essential component of death receptor pathways, is frequently inactivated, suggesting a critical role of death receptor-mediated apoptosis in suppression of N-Myc oncogenic activity. Elevated levels of N-Myc sensitize neuroblastoma cells to apoptosis induced by various death ligands. Using tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis as a model, we define the mechanism underlying the sensitization effect. In neuroblastoma cells with increased expression of N-Myc, TRAIL triggers high levels of caspase-8 activation and Bid cleavage, leading to release of cytochrome c and Smac/DIABLO from mitochondria. However, the apoptotic process requires Smac/DIABLO, but not cytochrome c-mediated caspase-9 activation. N-Myc sensitizes neuroblastoma cells to TRAIL by up-regulating TRAIL receptor-2/DR5/KILLER and Bid. Moreover, DR5 mRNA is increased after N-Myc overexpression, and the human DR5 promoter contains two noncanonical E-boxes critical for the transcriptional activation by N-Myc. These findings establish a mechanistic link between N-Myc and death receptor machinery, which may serve as a checkpoint to guard the cell from N-Myc-initiated tumorigenesis.
引用
收藏
页码:9474 / 9481
页数:8
相关论文
共 77 条
  • [1] Safety and antitumor activity of recombinant soluble Apo2 ligand
    Ashkenazi, A
    Pai, RC
    Fong, S
    Leung, S
    Lawrence, DA
    Masters, SA
    Blackie, C
    Chang, L
    McMurtrey, AE
    Hebert, A
    DeForge, L
    Koumenis, IL
    Lewis, D
    Harris, L
    Bussiere, J
    Koeppen, H
    Shahrokh, Z
    Schwall, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) : 155 - 162
  • [2] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [3] ASKEW DS, 1991, ONCOGENE, V6, P1915
  • [4] p14ARF links the tumour suppressors RB and p53
    Bates, S
    Phillips, AC
    Clark, PA
    Stott, F
    Peters, G
    Ludwig, RL
    Vousden, KH
    [J]. NATURE, 1998, 395 (6698) : 124 - 125
  • [5] Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma
    Berwanger, B
    Hartmann, O
    Bergmann, E
    Bernard, S
    Nielsen, D
    Krause, M
    Kartal, A
    Flynn, D
    Wiedemeyer, R
    Schwab, M
    Schäfer, H
    Christiansen, H
    Eilers, M
    [J]. CANCER CELL, 2002, 2 (05) : 377 - 386
  • [6] BIEDLER JL, 1973, CANCER RES, V33, P2643
  • [7] TRAIL receptor-2 signals apoptosis through FADD and caspase-8
    Bodmer, JL
    Holler, N
    Reynard, S
    Vinciguerra, P
    Schneider, P
    Juo, P
    Blenis, J
    Tschopp, J
    [J]. NATURE CELL BIOLOGY, 2000, 2 (04) : 241 - 243
  • [8] Stable suppression of tumorigenicity by virus-mediated RNA interference
    Brummelkamp, TR
    Bernards, R
    Agami, R
    [J]. CANCER CELL, 2002, 2 (03) : 243 - 247
  • [9] Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961
  • [10] Cui HJ, 2002, MOL CANCER THER, V1, P679